Chronic stress and oxidative stress as common factors of the pathogenesis of depression and Alzheimer's disease: The role of antioxidants in prevention and …

G Juszczyk, J Mikulska, K Kasperek, D Pietrzak… - Antioxidants, 2021 - mdpi.com
There is a growing body of scientific research showing the link between depression and
dementia in Alzheimer's disease (AD). The chronic stress contributes to the formation of …

Antioxidants in Alzheimer's disease: Current therapeutic significance and future prospects

P Pritam, R Deka, A Bhardwaj, R Srivastava, D Kumar… - Biology, 2022 - mdpi.com
Simple Summary Alzheimer's disease (AD) is the most common neurodegenerative disease,
intensifying impairments in cognition, behavior, and memory. Histopathological AD …

Bace1 inhibitors for Alzheimer's disease: the past, present and any future?

FH Bazzari, AH Bazzari - Molecules, 2022 - mdpi.com
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most
common cause of dementia in the elderly. The complexity of AD has hindered the …

[HTML][HTML] Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase

S Ahmed, ST Khan, MK Zargaham, AU Khan… - Biomedicine & …, 2021 - Elsevier
Abstract Alzheimer's disease (AD), is the most common type of dementia primarily affecting
the later years of life. Its prevalence is likely to increase in any aging population and will be a …

Alzheimer's disease, inflammation, and the role of antioxidants

B Sinyor, J Mineo, C Ochner - Journal of Alzheimer's disease …, 2020 - content.iospress.com
Abstract The World Health Organization refers to Alzheimer's disease (AD) as a global
health priority. As the average age of the world's population is increasing, so too is the rate …

The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer's disease: therapeutic implications and future …

MC Jurcău, FL Andronie-Cioara, A Jurcău, F Marcu… - Antioxidants, 2022 - mdpi.com
Alzheimer's disease (AD), the most common form of dementia, has increasing incidence,
increasing mortality rates, and poses a huge burden on healthcare. None of the currently …

Attenuation of Nrf2/Keap1/ARE in Alzheimer's disease by plant secondary metabolites: A mechanistic review

S Fakhri, M Pesce, A Patruno, SZ Moradi, A Iranpanah… - Molecules, 2020 - mdpi.com
Alzheimer's disease (AD) is a progressive neuronal/cognitional dysfunction, leading to
disability and death. Despite advances in revealing the pathophysiological mechanisms …

A triterpenoid lupeol as an antioxidant and anti-neuroinflammatory agent: impacts on oxidative stress in Alzheimer's disease

JS Park, IU Rehman, K Choe, R Ahmad, HJ Lee… - Nutrients, 2023 - mdpi.com
Alzheimer's disease (AD) is the most common neurodegenerative disease illustrated by
neuronal dysfunctions, leading to memory weaknesses and personality changes mostly in …

Contributions of DNA damage to Alzheimer's disease

X Lin, A Kapoor, Y Gu, MJ Chow, J Peng… - International journal of …, 2020 - mdpi.com
Alzheimer's disease (AD) is the most common type of neurodegenerative disease. Its typical
pathology consists of extracellular amyloid-β (Aβ) plaques and intracellular tau …

Research progress of multi-functional fluorescent probes for Alzheimer's disease monitoring

J Yang, Y Guo, M Pistolozzi, J Yan - Dyes and Pigments, 2021 - Elsevier
The diagnosis of Alzheimer's disease (AD) has proven to be difficult to achieve in clinical
practice, despite the extensive research on the subject. In addition to traditional biomarkers …